Mercuries & Associates (TPE:2905) Research & Development: NT$304 Mil (TTM As of Dec. 2025)


TPE:2905 Mercuries & Associates Ltd TPE:2905
67 GF Score
Price NT$14.80
GF Value NT$11.77
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Mercuries & Associates Research & Development?

Mercuries & Associates TPE:2905 -1.33% 67 Research & Development is NT$304 Mil as of Dec. 2025. GuruFocus rates TPE:2905 with a GF Score™ of 67/100 and a GF Value™ of NT$11.77 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mercuries & Associates's Research & Development for the three months ended in Dec. 2025 was NT$84 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$304 Mil.

Mercuries & Associates  (TPE:2905) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mercuries & Associates Research & Development Related Terms

Mercuries & Associates Research & Development Historical Data

* Premium members only.

The historical data trend for Mercuries & Associates's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercuries & Associates Research & Development Chart

Mercuries & Associates Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 225.50 251.83 295.60 298.76 304.25

Mercuries & Associates Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.12 71.77 74.88 73.28 84.32
TPE:2905
67GF Score
Mercuries & Associates Ltd TPE:2905
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercuries & Associates Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$304 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$304 Mil mean?
Mercuries & Associates (TPE:2905) has a Research & Development of NT$304 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Mercuries & Associates and its competitors.
Is Mercuries & Associates' Research & Development too high?
Mercuries & Associates' current Research & Development is NT$304 Mil. Overall, Mercuries & Associates has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mercuries & Associates' Research & Development compare to AFL and MET?
Mercuries & Associates' Research & Development of NT$304 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mercuries & Associates and its competitors. Mercuries & Associates's current Research & Development is NT$304 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercuries & Associates stock overvalued right now?
Based on GuruFocus' analysis, Mercuries & Associates (TPE:2905) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$11.77, compared to a current price of NT$14.80 — trading 25.7% above its estimated fair value. The current Research & Development is NT$304 Mil. Mercuries & Associates' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mercuries & Associates (TPE:2905), the current Research & Development is NT$304 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercuries & Associates (TPE:2905) Overvalued in 2026?

Based on GuruFocus' analysis, Mercuries & Associates stock appears to be overvalued. The current stock price of NT$14.80 is trading 25.7% above its estimated GF Value™ of NT$11.77. GuruFocus considers Mercuries & Associates to be Modestly Overvalued.

Key valuation signals for TPE:2905:

  • Research & Development: NT$304 Mil
  • GF Value™: NT$11.77 vs. price of NT$14.80 (25.7% above fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the TPE:2905 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mercuries & Associates Business Description

Address No. 145, Section 2, Chien Kuo North Road, Taipei, TWN
Mercuries & Associates Ltd is mainly engaged in finance and investment. The company is engaged in diversified businesses such as insurance, food and beverage, pharmaceutical, and IT integration. The segment of the company include Life insurance, Retail, Food and beverage, Food, IT service, Pharmaceutical, and Others. The company derives maximum revenue from the Life Insurance segment. Geographically, the company operates in domestic regions only.
67GF Score

Get the complete analysis for TPE:2905

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.80
Price
NT$11.77
GF Value